基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I am a Translational Neuroscientist with expertise in dementia epidemiology, based across Imperial College London and Aga Khan University Kenya; and affiliated as a Senior Scientist with Karolinska Institutet. My primary role is Programme and Biomarker Lead for one of the world’s largest and deeply-phenotyped, longitudinal dementia-prevention programme (The CHARIOT:PRO studies) co-funded by Janssen R&D, Merck, Takeda and Gates Foundation; with > 2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput. At the Brain and Mind Institute Kenya, I am developing capacity for dementia and healthy brain aging research, education, and care while collaborating with Mental Health and Neuroscience subject experts, clinicians, and educators across the Aga Khan University, to ultimately build the neuroscience capacity and strength at the University. I am also an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute, University of San Francisco, California, USA.
In 2018, I initiated the AFRICA-FINGERS project (as Principal Investigator) that aims to promote healthy ageing and mitigate brain health and biomarker-access inequalities through culturally appropriate, sustainable multimodal intervention strategies in Sub-Saharan African populations. I am co-Lead of the World-Wide FINGERS Biomarker Consortium, Global CEOi/Davos Alzheimer’s Collaborative workstream on Implementation of Blood-based-biomarkers in Clinical Practice and on the Executive committee for the Biofluids-biomarker-based PIA of the Alzheimer’s Association ISTAART (2018 - present). I am also co-founder of the Female Brain and Endocrine Research (FEMBER) consortium.
Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol (2010-2014), my current research focuses on elucidating dementia prevention bio-mechanistic pathways and strategies across diverse populations, adopting a translational approach integrating human clinical studies with experimental animal models; with multiple grants and awards to execute this work. In addition, I lead multinational initiatives to address gender and racial disparities in medical research and academia as part of the Opportunity Committee at Imperial College and further sit on the Board of Trustees of the British Society for Neuroendocrinology as the Equality and Diversity Inclusion Lead.
Overall, my work is at the forefront of translational neuroscience, bringing together fundamental discoveries in neuroscience with the goal of improving human health and wellbeing.
Research Interests
Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Brain, Behavior, and Immunity (2024): 499-509
ALZHEIMERS & DEMENTIAno. 7 (2024): 4486-4498
Alzheimer's & dementia : the journal of the Alzheimer's Associationno. 6 (2024): 4290-4314
Nature Agingno. 5 (2023): 463-465
Brain, behavior, & immunity - health (2023): 100592
AmanPreet Badhwar,Yael Hirschberg,Natalia Valle Tamayo,M Florencia Iulita,Chinedu T Udeh-Momoh,Anna Matton,Rawan M Tarawneh,Robert A Rissman,Aurélie Ledreux,Charisse N Winston,Arsalan S Haqqani, Alzheimer’s Association International Society to Advance Alzheimer's Research and Treatment, BBB-EWG
bioRxiv : the preprint server for biologyno. 7 (2023): 4411-4422
Load More
Author Statistics
#Papers: 50
#Citation: 1242
H-Index: 10
G-Index: 19
Sociability: 6
Diversity: 2
Activity: 20
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn